Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01332 TOUYUN BIOTECH
RT Nominal unchange0.165 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others218,379-24.845%290,570327,361150,38329,264
Land & other Lease Assets92,2521.698%90,712108,58921,81723,427
Intangible Assets0--2771,62410,54610,741
Interests in Asso. & JCEs0--000209,206
Other Non-current Assets134,225-27.103%184,129318,937320,686249,002

444,856-21.360%565,688756,511503,432521,640
Current Assets
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Inventories15,249-57.181%35,61332,76633,74129,571
Trade Receivables27,139-34.518%41,44566,28758,68554,763
Cash & Bank Balances34,493-73.073%128,09860,198142,44040,457
Other Current Assets85,603-26.743%116,853108,966233,642239,970
Assets Held for Sale0--0000

162,484-49.541%322,009268,217468,508364,761
Current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Trade Payables17,961-36.576%28,31937,87529,96732,154
S-T Debt & Leases179,355-10.690%200,822310,657214,530250,761
Other Current Liabilities183,3971.406%180,855181,029162,98148,781
Liab asso w/ Assets Held for Sale0--0000

380,713-7.142%409,996529,561407,478331,696
Net Current Assets(218,229)148.024%(87,987)(261,344)61,03033,065
Total Assets Less Current Liabilities226,627-52.559%477,701495,167564,462554,705
Non-current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
L-T Debt & Leases205,5545.851%194,1928,1228,09310,138
Other Non-current Liabilities0--0000

205,5545.851%194,1928,1228,09310,138
Capital and Reserves
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
  Share Capital112,2380.000%112,238112,238110,94697,973
  Reserves(113,086)--151,721357,679377,097443,232
  Others0--0000
Shareholders' Funds(848)--263,959469,917488,043541,205
Non-controlling Interests21,92112.128%19,55017,12868,3263,362
Others0--0000

21,073-92.567%283,509487,045556,369544,567
Commitments and Contingent Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Commitments3,9151.137%3,8714,70853,808517
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 05/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders ($)HKD -47,969,000
%Change-42.861%
EPS / (LPS)HKD -0.017
NBV Per Share ($)HKD -0.017
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.